FdaApplication
ANDA 215969
Identifiers
- fda_app_no: ANDA215969
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2024-07-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATROPINE SULFATE | ATROPINE SULFATE | 1MG/ML (1MG/ML) | SOLUTION;INTRAVENOUS |
| ATROPINE SULFATE | ATROPINE SULFATE | 0.4MG/ML (0.4MG/ML) | SOLUTION;INTRAVENOUS |
2 products